Cutaneous myiasis is a parasitic infestation of the skin caused by larvae of certain fly species, primarily affecting individuals in tropical and subtropical regions. It is clinically significant due to the potential for secondary infections and complications. Accurate coding with ICD-10 Code B87.0 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.
What is ICD-10 Code B87.0 for Cutaneous myiasis?
ICD-10 Code B87.0 represents Cutaneous myiasis, a condition characterized by the invasion of the skin by fly larvae. This code should be used when documenting cases of cutaneous myiasis in clinical settings, particularly when there is a clear identification of the infestation. It is essential for accurate billing and tracking of this condition in healthcare systems.
ICD-10 Code B87.0 – Clinical Definition and Explanation of Cutaneous myiasis
Cutaneous myiasis is caused by the larvae of certain flies, which can penetrate the skin, leading to painful lesions and potential secondary infections. The condition requires medical attention to prevent complications and manage symptoms effectively.
Key Clinical Features:
- Presence of painful, raised lesions on the skin
- History of exposure to infested environments
- Possible discharge or foul odor from lesions
- Signs of secondary bacterial infection
ICD-10 Code B87.0 for Cutaneous myiasis – SOAP Notes & Clinical Use
ICD-10 Code B87.0 is utilized in SOAP notes to document the presence of cutaneous myiasis, aiding in the assessment of symptoms, diagnosis, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
What Does ICD-10 Code B87.0 for Cutaneous myiasis Mean in SOAP Notes?
In SOAP notes, ICD-10 Code B87.0 connects subjective patient-reported symptoms with objective clinical findings, facilitating a formal diagnosis. This code supports continuity of care, accurate billing, and adherence to EHR documentation standards.
Treatment Options for ICD-10 Code B87.0 – Cutaneous myiasis
Cutaneous myiasis requires prompt treatment to alleviate symptoms and prevent complications. Hospitalization may be necessary in severe cases.
Antibiotic Therapy:
- First-line: Ivermectin (single dose)
- Alternative: Albendazole (if indicated)
- Duration: Typically a single dose, may vary based on severity
Supportive Care:
- Wound care to clean and dress lesions
- Pain management with analgesics
- Monitoring for signs of secondary infection
Infection Control:
- Isolate affected individuals if necessary
- Educate on hygiene practices to prevent spread
- Implement vector control measures in endemic areas
How to Document Symptoms of Cutaneous myiasis (ICD-10 B87.0) in SOAP Notes
Subjective:
- Patient reports painful lesions on the skin
- History of travel to endemic areas
- Complaints of itching and discomfort
- Noted foul odor from lesions
Objective:
- Visible raised lesions with central punctum
- Discharge noted from lesions
- Signs of erythema and swelling
- Vital signs stable, no fever present
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Cutaneous myiasis (ICD-10 Code B87.0)
Assessment:
- Diagnosis: Cutaneous myiasis, moderate severity
- ICD-10 Code: B87.0
- Contributing factors: Recent travel to endemic region
- Possible secondary infection noted
Plan:
- Administer Ivermectin as first-line treatment
- Educate patient on wound care and hygiene
- Schedule follow-up in one week to monitor healing
- Consider referral to infectious disease specialist if no improvement
Treatment & Plan Section for ICD-10 Code B87.0 – Cutaneous myiasis
- First-line pharmacologic treatment: Ivermectin
- Non-pharmacologic strategies: Proper wound care and hygiene
- Monitoring practices: Regular follow-up appointments
- Patient education on prevention and symptom management
Using ICD-10 Code B87.0 for Cutaneous myiasis in Billing & SOAP Note Compliance
- Select appropriate ICD-10 code based on clinical findings
- Document symptoms clearly in Subjective (S) and Objective (O) sections
- Ensure treatment plans align with clinical guidelines for justified billing
- Include relevant CPT codes that correspond with the diagnosis
Related ICD-10 Codes Often Used with Cutaneous myiasis
- A00.0 – Cholera due to Vibrio cholerae
- A01.0 – Typhoid fever
- A02.0 – Salmonella enteritis
ICD-10 Code B87.0 in Medical Billing and Insurance for Cutaneous myiasis
ICD-10 Code B87.0 is crucial for billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Document all relevant patient history and symptoms
- Use the code in conjunction with appropriate CPT codes for services rendered
- Ensure compliance with payer guidelines for accurate reimbursement
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, Level 3 |
| 99285 | Emergency department visit, high severity |
| 10060 | Incision and drainage of abscess |
Frequently Asked Questions
Common Questions About Using ICD-10 Code B87.0 for Cutaneous myiasis
What are the common symptoms of cutaneous myiasis?
Common symptoms include painful, raised lesions on the skin, itching, and possible discharge. Patients may also report a foul odor from the lesions, indicating the presence of larvae.
How is cutaneous myiasis treated?
Treatment typically involves the administration of Ivermectin or Albendazole, along with proper wound care to prevent secondary infections. Severe cases may require hospitalization.
Is cutaneous myiasis contagious?
Cutaneous myiasis is not contagious; it occurs due to exposure to environments where fly larvae are present. Preventive measures include maintaining hygiene and avoiding infested areas.
When should I seek medical attention for cutaneous myiasis?
Medical attention should be sought if lesions are painful, show signs of infection, or do not improve with initial treatment. Prompt care can prevent complications.
